Home > M&A deals 2014 > Bristol-Myers Squibb Co. acquires Galecto, Inc.
Add-on Acquistion · Life Science · November 2014

Bristol-Myers Squibb Co. acquires Galecto, Inc.

On November 3, 2014, Bristol-Myers Squibb Co. acquired Galecto, Inc., a life science company in Denmark.

Deal at a glance

AnnouncedNovember 3, 2014 TypeAdd-on Acquistion TargetGalecto, Inc. Buyer Bristol-Myers Squibb Co. SectorLife Science LocationDenmark ValueNot disclosed

Target company

Galecto, Inc.
Denmark
Life Sciencesector
1985founded
Activestatus
View the company profile →

Buyer

Bristol-Myers Squibb Co.
Company · 36 deals on record
  • 12th transaction in life science
  • 1st transaction in Denmark
36deals, all time
17in this sector
2022latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Turning Point Therapeutics, Inc.Same lead buyer · Jun 2022
Chr. Olesen Synthesis A/SSame sector and country · Oct 2026
Intomics A/SSame sector and country · May 2022
Fertin Pharma A/SSame sector and country · Jul 2021

Questions about this deal

Who acquired Galecto, Inc.?Bristol-Myers Squibb Co. acquired Galecto, Inc. on November 3, 2014.

What type of deal was it?It was a add-on acquistion in the life science sector in 2014.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).